Results for biontech merck

Add to feed Create your own feed

Latest

Pfizer and BioNTech said a booster shot of their COVID-19 vaccine restored efficacy to 95.6% against the virus, including the Delta variant, according to data from a Phase III trial

Diabetics among those who could benefit from new Merck COVID-19 treatment

A booster dose of the COVID-19 vaccine developed by Pfizer and German partner BioNTech SE was 95.6 per cent effective against the coronavirus.

Pfizer and BioNTech on Thursday said a booster shot of their COVID-19 vaccine was 95.6% effective in preventing infection from the virus compared to those who did not receive a third dose.

The European Union's drug regulator expects to announce the results of its review of Moderna's COVID-19 booster vaccine next week and also to start a rolling review of Merck's antiviral oral pill.

Pfizer and BioNTech Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine (Pfizer)

Pfizer, BioNTech say COVID-19 booster shot showed high efficacy in large study

tweet picture

Pfizer Inc and German partner BioNTech SE on Thursday said data from a Phase III trial demonstrated high efficacy of a booster dose of their COVID-19 vaccine against the virus, including the Delta variant.

tweet picture

Pfizer, Merck next-gen pneumococcal vaccines score key CDC panel's backing on way to rival rollouts

Pfizer, BioNTech say COVID-19 booster shot showed high efficacy in large study

Loading
Loading

Most relevant

Merck's COVID-19 pill cuts risk of death, hospitalization by 50% in study

tweet picture

The makers of the Pfizer-BioNTech Covid vaccine will soon ask regulators to approve its use in children 5 years and over, and are getting ready to make smaller doses of the vaccine for younger children, according to a BioNTech founder.

Merck sells federally financed Covid pill to U.S. for 40 times what it costs to make by @fastlerner 

Pharma company Merck used government funds to develop a new Covid medicine. The drug costs them less than $18 to produce. They’re charging the U.S. government $712 — 40 times the price to produce it. Their sales could reach $7 billion by the end of the year. An outrage.

Pfizer, Biontech, Novavax, Moderna shares plunge to session lows after U.S. backs waiving patent protections on Covid vaccines

tweet picture

Pfizer and BioNTech say their COVID-19 vaccine is more than 90% effective

BREAKING: Biden administration official: Merck to help produce rival Johnson & Johnson's coronavirus vaccine to speed up supply.

If approved, the Pfizer BioNTech vaccine will be manufactured in Germany and Belgium. We have ordered 40 million doses. Their transport is temperature and time critical. Let’s hope there are no issues that would prevent free and fast movement of goods at our borders in January.

. Project Warp Speed!  Well done Pfizer-Biontech and well done Mr. President!  This is what will save lives, not Biden’s empty talk. This is called SCIENCE Biden, Democrats, and media!  And President Trump should tout it all day long!

Pharmaceutical CEO salaries: Merck: $55 million Pfizer: $50M Eli Lilly: $30M Johnson & Johnson: $26M AbbVie: $23M This greed must end. The function of prescription drugs must be to protect and improve human health—not make corporate executives unfathomably rich.

Loading
Loading